Literature DB >> 8126201

Comparison of siderophore production and utilization in pathogenic and environmental isolates of Yersinia enterocolitica.

C E Chambers1, P A Sokol.   

Abstract

Yersinia enterocolitica strains of serotypes lethal to mice have been reported previously to produce an endogenous siderophore. In this study, an ethyl acetate-extractable siderophore was characterized and given the name yersiniophore. Yersiniophore was produced by 16 of 16 human isolates of serotypes O:4, O:4,32, O:8, O:21, and one nonhuman isolate of serotype O:21. It was not produced by isolates of serotype O:3, O:5, or O:9. One strain of Yersinia pseudotuberculosis produced yersiniophore, but strains of Yersinia kristensenii, Yersinia frederiksenii, and Yersinia intermedia did not produce or utilize yersiniophore. Food and water isolates of Y. enterocolitica produced a water-soluble siderophore but not yersiniophore. Sixty-two strains of Y. enterocolitica including 42 isolates from human infections, 2 animal isolates, and 18 water and food isolates were examined for utilization of yersiniophore, the water-soluble siderophore, and ferrioxamine. Yersiniophore promoted growth rate, iron binding, and uptake in 17 of 62 strains, all of which produced yersiniophore. Ten of 17 food and water isolates and one human isolate were capable of utilizing the water-soluble siderophore. Utilization studies suggest that at least one additional water-soluble siderophore may be produced. Ferrioxamine promoted the growth of 60 of 62 strains examined; however, only the 17 strains which produced yersiniophore actively accumulated [59Fe]ferrioxamine. Yersiniophore production and utilization may be important in clinical infections since all human strains belonging to serotype O:8 produced yersinophore. The water-soluble siderophore was not detected in human isolates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126201      PMCID: PMC262965          DOI: 10.1128/jcm.32.1.32-39.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Siderochrome production by Yersinia pestis and its relation to virulence.

Authors:  A Wake; M Misawa; A Matsui
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

4.  The isolation and characterization of a hydroxamic acid (aerobactin) formed by Aerobacter aerogenes 62-I.

Authors:  F Gibson; D I Magrath
Journal:  Biochim Biophys Acta       Date:  1969-11-18

Review 5.  Advances in the use of iron-chelating agents for the treatment of iron overload.

Authors:  B Modell
Journal:  Prog Hematol       Date:  1979

6.  The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients.

Authors:  J R Boelaert; H W van Landuyt; Y J Valcke; B Cantinieaux; W F Lornoy; J L Vanherweghem; P Moreillon; J M Vandepitte
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

Review 7.  Microbial iron compounds.

Authors:  J B Neilands
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  Characteristics of virulence in human isolates of Yersinia enterocolitica.

Authors:  D A Schiemann; J A Devenish; S Toma
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

9.  Pathogenic properties of Yersinia enterocolitica.

Authors:  V Mors; C H Pai
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  Accumulation of iron by yersiniae.

Authors:  R D Perry; R R Brubaker
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

View more
  9 in total

1.  Sequestration and scavenging of iron in infection.

Authors:  Nermi L Parrow; Robert E Fleming; Michael F Minnick
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

Review 2.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Physical and structural characterization of yersiniophore, a siderophore produced by clinical isolates of Yersinia enterocolitica.

Authors:  C E Chambers; D D McIntyre; M Mouck; P A Sokol
Journal:  Biometals       Date:  1996-04       Impact factor: 2.949

Review 4.  Regulation of iron transport systems in Enterobacteriaceae in response to oxygen and iron availability.

Authors:  Chandra Carpenter; Shelley M Payne
Journal:  J Inorg Biochem       Date:  2014-01-22       Impact factor: 4.155

5.  Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis.

Authors:  S W Bearden; J D Fetherston; R D Perry
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Analysis of the pesticin receptor from Yersinia pestis: role in iron-deficient growth and possible regulation by its siderophore.

Authors:  J D Fetherston; J W Lillard; R D Perry
Journal:  J Bacteriol       Date:  1995-04       Impact factor: 3.490

7.  Isolation, serotypes, and virulence-associated properties of Yersinia enterocolitica from the tonsils of slaughter hogs.

Authors:  H Hariharan; J S Giles; S B Heaney; S M Leclerc; R D Schurman
Journal:  Can J Vet Res       Date:  1995-07       Impact factor: 1.310

8.  Proferrioxamine synthesis in Erwinia amylovora in response to precursor or hydroxylysine feeding: metabolic profiling with liquid chromatography-electrospray mass spectrometry.

Authors:  G J Feistner
Journal:  Biometals       Date:  1995-10       Impact factor: 2.949

Review 9.  The diversity and utility of arylthiazoline and aryloxazoline siderophores: challenges of total synthesis.

Authors:  Karolina Kamińska; Andrzej Mular; Evgenia Olshvang; Nils Metzler Nolte; Henryk Kozłowski; Elżbieta Wojaczyńska; Elżbieta Gumienna-Kontecka
Journal:  RSC Adv       Date:  2022-09-07       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.